DC Field | Value | Language |
---|---|---|
dc.contributor.author | J T Lee | - |
dc.contributor.author | T J Lee | - |
dc.contributor.author | C H Kim | - |
dc.contributor.author | Nam-Soon Kim | - |
dc.contributor.author | T K Kwon | - |
dc.date.accessioned | 2017-04-19T09:14:01Z | - |
dc.date.available | 2017-04-19T09:14:01Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | 10.1016/j.canlet.2009.01.035 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/9001 | - |
dc.description.abstract | Reticulons (RTNs) are a group of integral membrane proteins that have no homology to other known apoptosis-related domains. Herein, we found that RTN3 overexpressing Caki cells were sensitive to TRAIL-mediated apoptosis. RTN3-induced down-regulation of c-FLIP was recovered by pan-caspase inhibitor, z-VAD to basal levels in TRAIL-treated cells. The forced expression of c-FLIP attenuated the TRAIL-mediated apoptosis in RTN3 overexpressing cells. In addition, RTN3 over-expression provoked the enhanced protein levels in DR4 and DR5 as well as levels in DR5 surface protein but slight increase in DR4 surface protein. RTN3-mediated enhancement of TRAIL-induced apoptosis was markedly blocked by the DR5/Fc chimera or DR5 siRNA, indicating that the sensitization by RTN3 was mainly mediated through interactions of TRAIL with its receptors, DR5. Over-expression of RTN3 also enhanced TNF-a and Fas-mediated apoptosis. Taken together, over-expression of RTN3 might increase DR5 surface protein and concomitantly more activate caspase pathways, which cause the c-FLIP cleavage and enhancement of TRAIL-mediated apoptosis. | - |
dc.publisher | Elsevier | - |
dc.title | Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP | - |
dc.title.alternative | Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP | - |
dc.type | Article | - |
dc.citation.title | Cancer Letters | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 192 | - |
dc.citation.startPage | 185 | - |
dc.citation.volume | 279 | - |
dc.contributor.affiliatedAuthor | Nam-Soon Kim | - |
dc.contributor.alternativeName | 이정태 | - |
dc.contributor.alternativeName | 이태진 | - |
dc.contributor.alternativeName | 김철희 | - |
dc.contributor.alternativeName | 김남순 | - |
dc.contributor.alternativeName | 권택규 | - |
dc.identifier.bibliographicCitation | Cancer Letters, vol. 279, no. 2, pp. 185-192 | - |
dc.identifier.doi | 10.1016/j.canlet.2009.01.035 | - |
dc.subject.keyword | RTN3 | - |
dc.subject.keyword | TRAIL | - |
dc.subject.keyword | apoptosis | - |
dc.subject.keyword | DR5 | - |
dc.subject.keyword | c-FLIP | - |
dc.subject.local | RTN3 | - |
dc.subject.local | TRAIL | - |
dc.subject.local | apoptosis | - |
dc.subject.local | Apoptosis | - |
dc.subject.local | DR5 | - |
dc.subject.local | c-FLIP | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.